Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer Chemotherapy
FEMT-PC
Effect of Ziwu Liuzhu Five-Element Music Therapy on Psychological Distress in Patients With Pancreatic Cancer Undergoing Chemotherapy: A Multicenter, Non-Inferiority Randomized Controlled Trial
2 other identifiers
interventional
320
1 country
1
Brief Summary
Ziwu Liuzhu Five-Element Music Therapy is a non-pharmacological intervention grounded in the traditional Chinese medicine theory of "five tones corresponding to the five viscera and five emotions," integrated with the chronomedicine framework of Ziwu Liuzhu (midnight-noon meridian flow). It delivers specific musical modes at designated two-hour intervals to resonate with meridian qi and blood, achieving the therapeutic goals of "time-matched music for organ-specific regulation." Existing meta-analyses have confirmed that five-element music therapy significantly alleviates anxiety and depression and improves quality of life in cancer patients; however, no dedicated study has been conducted in pancreatic cancer patients undergoing chemotherapy. This is a multicenter, prospective, parallel-group, non-inferiority randomized controlled trial. A total of 320 pancreatic cancer patients with mild-to-moderate anxiety receiving NALIRIFOX or AG (nab-paclitaxel + gemcitabine) chemotherapy will be enrolled and randomly assigned in a 1:1 ratio to either the Ziwu Liuzhu Five-Element Music Therapy group or the Mindfulness-Based Stress Reduction (MBSR) group. The intervention group receives 20-minute sessions, three times daily, for 8 weeks of Ziwu Liuzhu Five-Element Music listening. The control group receives an 8-week standard MBSR program consisting of twice-daily home practice and weekly online group sessions. The primary outcome is the change in HADS-Anxiety score from baseline to week 8. Secondary outcomes include depression (HADS-D), quality of life (EORTC QLQ-C30), and biomarkers (NLR, MLR, albumin, etc.). This trial aims to demonstrate that Ziwu Liuzhu Five-Element Music Therapy is non-inferior to a standardized psychological intervention (MBSR) for improving Psychological Distress in pancreatic cancer patients during chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2026
CompletedStudy Start
First participant enrolled
August 28, 2026
CompletedFirst Posted
Study publicly available on registry
September 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
September 16, 2026
August 1, 2026
4 months
August 27, 2026
September 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the Hospital Anxiety and Depression Scale-Anxiety Score
Anxiety assessed using the Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A). Score ranges from 0 to 21, with higher scores indicating worse anxiety. The primary analysis is non-inferiority of Ziwu Liuzhu Five-Element Music Therapy compared to Mindfulness-Based Stress Reduction at week 8.
Baseline, Week 4, Week 8
Secondary Outcomes (5)
Change in the Hospital Anxiety and Depression Scale-Depression Score
Baseline, Week 4, Week 8
Change in Global Health Status/QoL Score on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30
Baseline, Week 4, Week 8
Change in Functional Subscales and Symptom Scores on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30
Baseline, Week 4, Week 8
Adherence: Practice Check-in Rate
Daily, summarized at Week 4, Week 8
Incidence of Adverse Events
Daily, summarized at Week 4, Week 8
Other Outcomes (7)
Change in Neutrophil-to-Lymphocyte Ratio (NLR)
Baseline, Week 4, Week 8
Change in Monocyte-to-Lymphocyte Ratio (MLR)
Baseline, Week 4, Week 8
Change in White Blood Cell Count(WBC)
Baseline, Week 4, Week 8
- +4 more other outcomes
Study Arms (2)
Ziwu Liuzhu Five-Element Music Therapy
EXPERIMENTALParticipants receive an 8-week Ziwu Liuzhu Five-Element Music Therapy program: three 20-minute sessions daily (Si period: Gong mode; Wu period: Zhi mode; You period: Yu mode). Delivered via bedside instruction during hospitalization and video supervision at home.
Mindfulness-Based Stress Reduction
ACTIVE COMPARATORParticipants receive an 8-week standard Mindfulness-Based Stress Reduction program: weekly online group sessions (60 min) + twice-daily home audio-guided practice (20 min).
Interventions
An 8-week program delivering Gong, Zhi, and Yu musical modes at Si, Wu, and You periods respectively, 20 min per session, 3 sessions daily. Music selected from a curated library based on patient preference.
An 8-week standard Mindfulness-Based Stress Reduction program consisting of weekly 60-minute online group sessions and twice-daily 20-minute home audio-guided practice sessions.
Eligibility Criteria
You may qualify if:
- Histologically or cytologically confirmed pancreatic cancer
- Receiving first-line neoadjuvant or adjuvant chemotherapy with NALIRIFOX or AG regimen
- ECOG performance status ≤ 2
- Life expectancy \> 3 months
- HAMA score 7-23 (mild-to-moderate anxiety)
- Ability to understand, communicate, and cooperate with the study; Voluntary signed informed consent
You may not qualify if:
- Severe psychiatric disorders, cognitive impairment, suicidal ideation, or unstable antipsychotic medication dosage
- Chemotherapy-related acute unstable conditions (severe myelosuppression, uncontrolled pain, active infection, or uncontrolled seizures)
- Severe hearing impairment or intolerance to music intervention
- Concurrent participation in other clinical trials
- Regular mindfulness meditation or yoga practice history (≥2 times/week for ≥3 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, 300060, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Jihui Hao
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The statistician responsible for data analysis is also masked to group allocation. Data are coded with randomization numbers and analyzed under blinded conditions.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 27, 2026
First Posted
September 1, 2026
Study Start
August 28, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
January 31, 2027
Last Updated
September 16, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to unresolved agreements on data sharing across the four participating centers, and to ensure protection of patient privacy in accordance with institutional and ethical requirements.